secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prime Medicine, Inc. (PRME)
CIK:        0001894562
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001628280-24-004785
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Prime Medicine reports preliminary cash of ~$135.2M as of Dec 31, 2023
----------------------------------------------------------------------

- Preliminary unaudited cash, equivalents, short-term investments, and restricted cash total ~$135.2M.
- Excluding $13.5M restricted cash, liquid assets are ~$121.7M.
- Company has not yet completed year-end close; final results may differ materially.
- Estimates are management-prepared and not audited; no assurance of final figures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894562/000162828024004785/0001628280-24-004785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894562/000162828024004785/prme-20240214.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-004785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer